How CancerIQ helps Adventist Health identify high-risk patients to reduce hereditary cancer deaths

As an OB-GYN, Dr. Candace Westgate has those days when she must deliver bad news—a cancer diagnosis—to a patient.

But in recent years, some of those cases have come using genetic testing to identify high-risk patients earlier to preempt or prevent the disease.

It’s one of the reasons Westgate became a champion of the Early All-Around Detection (AHEAD) Program at Adventist Health, the 21 hospital-based health system where she works in St. Helena, California. Adventist Health operates hospitals in California, Oregon, and Hawaii.

Read the full story by Heather Landi on FierceHealthcare